Stuart A. Arbuckle, EVP, Chief Commercial Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7 shares at $222.47 ($2K) on 2020-11-16, disclosed to the SEC on 2020-11-18.
Scheduled sale ($2k) by EVP, Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $222.47 | 2 | $445 | 28.4% |
| 2 | $224.11 | 5 | $1K | 71.6% |
| Total | $223.64 avg | 7 | $2K | 100% |
| Filing → |
| VRTX | SELL | 2024-02-23 | $3.0M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2024-02-13 | $3.6M | — | Filing → |